Electromed, Inc. (NYSE:ELMD) Director Sells $1,140,573.12 in Stock

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 38,954 shares of the stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $29.28, for a total transaction of $1,140,573.12. Following the transaction, the director now directly owns 32,622 shares of the company’s stock, valued at $955,172.16. This represents a 54.42 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Kathleen Skarvan also recently made the following trade(s):

• On Friday, February 14th, Kathleen Skarvan sold 8,640 shares of Electromed stock. The shares were sold at an average price of $32.25, for a total value of $278,640.00.

Electromed Stock Performance

Shares of NYSE ELMD opened at $29.36 on Thursday. Electromed, Inc. has a one year low of $13.74 and a one year high of $35.56. The firm has a market capitalization of $251.32 million, a P/E ratio of 39.15 and a beta of 0.33. The company’s fifty day moving average is $31.40 and its two-hundred day moving average is $25.15.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Electromed from a “strong-buy” rating to a “buy” rating in a report on Wednesday.

Institutional Trading of Electromed

A number of institutional investors have recently added to or reduced their stakes in ELMD. Russell Investments Group Ltd. purchased a new position in Electromed in the fourth quarter valued at about $37,000. IFP Advisors Inc acquired a new stake in shares of Electromed in the 4th quarter worth approximately $59,000. Quantbot Technologies LP purchased a new position in Electromed in the 4th quarter valued at approximately $99,000. Bank of America Corp DE raised its holdings in Electromed by 179.2% during the fourth quarter. Bank of America Corp DE now owns 4,004 shares of the company’s stock worth $118,000 after purchasing an additional 2,570 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Electromed during the fourth quarter worth $119,000. Hedge funds and other institutional investors own 40.82% of the company’s stock.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.